advertisement

---

Reinehr S 8

Showing records 1 to 8 | Display all abstracts from Reinehr S

84995 Current State of Primary Neuroprotection in Glaucoma
Reinehr S
Klinische Monatsblätter für Augenheilkunde 2020; 237: 143-149

---

84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Reinehr S
Frontiers in pharmacology 2019; 10: 1381

---

84995 Current State of Primary Neuroprotection in Glaucoma
Grotegut P
Klinische Monatsblätter für Augenheilkunde 2020; 237: 143-149

---

84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Gomes SC; Gassel CJ
Frontiers in pharmacology 2019; 10: 1381

---

84995 Current State of Primary Neuroprotection in Glaucoma
Tsai T
Klinische Monatsblätter für Augenheilkunde 2020; 237: 143-149

---

84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Asaad MA
Frontiers in pharmacology 2019; 10: 1381

---

84995 Current State of Primary Neuroprotection in Glaucoma
Wagner N; Joachim SC
Klinische Monatsblätter für Augenheilkunde 2020; 237: 143-149

---

84774 Intravitreal Therapy Against the Complement Factor C5 Prevents Retinal Degeneration in an Experimental Autoimmune Glaucoma Model
Stute G; Schargus M; Dick HB; Joachim SC
Frontiers in pharmacology 2019; 10: 1381

---